Advertisement
Screener

STEPAN COMPANY (SCL) Proceeds from Lines of Credit

1.8 / 5 stars · 43/120 Roast Me

STEPAN COMPANY Proceeds from Lines of Credit

STEPAN COMPANY (SCL) reported Proceeds from Lines of Credit of $19.89 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.

Financial Statements › Cash Flow › Financing Activities

us-gaap:ProceedsFromLinesOfCredit · last filed 2025-02-27

  • STEPAN COMPANY proceeds from lines of credit for the quarter ending 2023-12-31 was $13.71M, a 56.34% decline year-over-year.
  • STEPAN COMPANY proceeds from lines of credit for the quarter ending 2023-09-30 was -$18.45M, a 134.56% decline year-over-year.
  • STEPAN COMPANY proceeds from lines of credit for the quarter ending 2023-06-30 was -$14.40M, a 559.30% decline year-over-year.
  • STEPAN COMPANY proceeds from lines of credit for the quarter ending 2023-03-31 was $123.85M, a 25.56% increase year-over-year.
  • STEPAN COMPANY proceeds from lines of credit for fiscal 2024 was $19.89M, a 81.01% decline from fiscal 2023.
  • STEPAN COMPANY proceeds from lines of credit for fiscal 2023 was $104.72M, a 43.87% decline from fiscal 2022.
  • STEPAN COMPANY proceeds from lines of credit for fiscal 2022 was $186.55M, a 6420.48% increase from fiscal 2021.
  • STEPAN COMPANY proceeds from lines of credit for fiscal 2021 was $2.86M.
Period endProceeds from Lines of Credit 3 monthProceeds from Lines of Credit 6 monthProceeds from Lines of Credit 9 monthProceeds from Lines of Credit 12 month
2024-12-31$19.89M
10-K · filed 2025-02-27
2023-12-31$13.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
-$4.73M
derived: sum of 2 quarters · filed 2025-02-27
-$19.13M
derived: sum of 3 quarters · filed 2025-02-27
$104.72M
10-K · filed 2025-02-27
2023-09-30-$18.45M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
-$32.84M
derived: sum of 2 quarters · filed 2023-11-02
$91.00M
10-Q · filed 2023-11-02
$122.41M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30-$14.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$109.45M
10-Q · filed 2023-08-03
$140.86M
derived: sum of 3 quarters · filed 2025-02-27
$194.23M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31$123.85M
10-Q · filed 2023-05-04
$155.26M
derived: sum of 2 quarters · filed 2025-02-27
$208.63M
derived: sum of 3 quarters · filed 2025-02-27
$211.76M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$31.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$84.78M
derived: sum of 2 quarters · filed 2025-02-27
$87.92M
derived: sum of 3 quarters · filed 2025-02-27
$186.55M
10-K · filed 2025-02-27
2022-09-30$53.37M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$56.51M
derived: sum of 2 quarters · filed 2023-11-02
$155.14M
10-Q · filed 2023-11-02
$148.20M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$3.13M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03
$101.77M
10-Q · filed 2023-08-03
$94.83M
derived: sum of 3 quarters · filed 2024-02-29
$100.14M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$98.64M
10-Q · filed 2023-05-04
$91.70M
derived: sum of 2 quarters · filed 2024-02-29
$97.00M
derived: sum of 3 quarters · filed 2024-02-29
$51.83M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31-$6.94M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
-$1.63M
derived: sum of 2 quarters · filed 2024-02-29
-$46.81M
derived: sum of 3 quarters · filed 2024-02-29
$2.86M
10-K · filed 2024-02-29
2021-09-30$5.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
-$39.87M
derived: sum of 2 quarters · filed 2022-11-03
$9.80M
10-Q · filed 2022-11-03
2021-06-30-$45.17M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$4.50M
10-Q · filed 2022-08-04
2021-03-31$49.67M
10-Q · filed 2022-05-05

Similar stocks

Stock NameCountryMarket CapPE Ratio
Longevity Health Holdings, Inc. (XAGE)United States$0.006B-0.09
CHURCH & DWIGHT CO INC /DE/ (CHD)United States$22.622B30.81
ECOLAB INC. (ECL)United States$77.183B36.58
PROCTER & GAMBLE Co (PG)United States$338.763B21.26